I’m Alec, and I’m a now-fourth-year pharmacy student
currently on rotation with Dr. Melanie Nicol in Uganda. After a COVID-related
hiatus, this APPE rotation is now being offered again, so I’m privileged to be
able to participate as well as excited to share a few brief snapshots of my experience.
Let’s dive right in!
It wasn’t until my first day rounding with the infectious
disease team at Mulago Hospital—the largest public hospital in
Uganda’s capital of Kampala—that being surprised took on a new
meaning. As I shadowed the local physicians caring for patients with
cryptococcal meningitis and tuberculosis—two comorbidities commonly associated
with severe HIV—one of the doctors looked up from his chart and turned to
me.
“If a patient is taking PISA, would they need
metronidazole?”
“Uhhh,” I stammered. “Let me check.”
Quickly checking on a friend’s phone, I refreshed my
infectious disease knowledge, which had collected a semester’s worth of
mental dust. Recently having learned that piperacillin-tazobactam was
referred to as “PISA” in Uganda, I found that this common antibiotic’s broad
spectrum covers the anaerobic bacteria for which metronidazole is indicated. After
imparting this information to the doctor, he caught me off guard yet again:
“What about ornidazole?” He asked.
“What?”
“Ornidazole,” he repeated. “O-R-N-I-D-A-Z-O-L-E.”
I returned to the online spectrum I found, but to no avail.
I had never heard of this mystery drug, and it was not listed in the online
resource either. Slightly ashamed, I Googled the medication and saw that it is
in the same class as metronidazole and kills the same types of bacteria.
However, the drug is not even available in the United States. I explained to
the doctor that this medication is not much different than metronidazole, so
unless he wanted to treat a parasitic infection, piperacillin-tazobactam should
be sufficient.
My first surprise at this moment was the doctor’s confidence
in my abilities. To him, my white coat and identity as a fourth-year pharmacy
student meant I could be trusted to provide reliable information about
medications. After years of being expected to learn, I was now expected to apply and share the knowledge—a
truly daunting task. Second, I was surprised with the depth of knowledge one
must obtain to be an effective clinical pharmacist. Although the pharmacist
board exam emphasizes the top 200 medications as the most important drugs to
understand, this is different than practice. On hospital rounds or in the
pharmacy, it seems the most important medication is the one right in front of
you, whether it is in the top 200 or is not even used in the United States.
Although I was able to muster a reasonable answer to the
physician’s questions, our brief discussion was a reminder of the challenges
that lie ahead in my year of rotations. It will be a year of growth and
learning, that’s for sure, but also a year during which I will face uncertainty
and will be expected to apply knowledge rather than to simply memorize
information. I look forward to building my clinical acumen so that the trust
providers and patients have in me is not misplaced. And I can think of no
better place to begin my APPE experience than Uganda. Here, I am immersed in
the unfamiliar—exposed every day to new medicines, new places, and a new
culture. I hope that, by the end of this rotation, I will learn to thrive in
this environment, and I will be better prepared to meet the new challenges
offered in each of my upcoming rotations.
Over the next few days, I will finish rounding with the
infectious disease team. I will also embark on a much-anticipated safari to
Murchison National Park in Northwest Uganda. So, I certainly will not lack in
content for future blog entries, but, for today, I’ll sign off!
No comments:
Post a Comment